We report that activin profoundly alters epithelial branching morphogenesis of embryonic mouse salivary gland, pancreas and kidney rudiments in culture, indicating that it may play a role as a morphogen during mammalian organogenesis. In developing pancreas and salivary gland rudiments, activin causes severe disruption of normal lobulation patterns of the epithelium whereas follistatin, an activin-binding protein, counteracts the effect of activin. In the kidney, activin delays branching of the ureter bud and reduces the number of secondary branches. TGF-/3 induces a pattern of aberrant branching in the ureter bud derived epithelium distinct from that seen for activin. Reverse-transcriptase polymerase chain reaction, Northern hybridization and in situ hybridization analyses indicate that these developing tissues express the mRNA transcripts for activin subunits, follistatin or activin receptors. Our results are suggestive of a potential role for the activin-follistatin system as an intrinsic regulator of epithelial branching morphogenesis during mammalian organogenesis.
Introduction
Activins are proteins that regulate multiple biological events, including the release of several anterior pituitary hormones, proliferation of different cell types, erythropoiesis and neural cell survival (reviewed in Vale et al., 1990) . Activins also induce mesoderm during early development of amphibians (reviewed in Klein and Melton, 1994) and birds (Mitrani et al., 1990) . Activins (A, B, and AB) are hetero/homodimers of two closely related 0 subunits (flAflA, &@a and P,.&, respectively), and the two follicle-stimulating hormone (FSH) release suppressing inhibins (A and B) are dimers composed of an (Y subunit combined to either of the two 6 subunits (reviewed in Vale et al., 1990) . The three activin/inhibin monomeric glycoprotem that has inhibin-like FSHsuppressing activity but is structurally unrelated to inhibins and activins (reviewed in Michel et al., 1993) . It was later found indistinguishable from an activinbinding protein purified from rat ovaries (Nakamura et al., 1990) . Follistatin binds both activin (Nakamura et al., 1990; Shimonaka et al., 1991) and inhibin and it neutralizes the biological activity of activin, but not that of inhibin (reviewed in Michel et al., 1993) . Although most abundant in the gonads, the inhibitiactivin subunits (Meunier et al., 1988) and follistatin (Michel et al., 1990; Kogawa et al., 1991) are expressed in several extragonadal tissues in the adult rat, suggesting diverse biological roles for the activinfollistatin system. Interestingly, unlike many other known specific binding proteins which can release the growth factor they adhere to, follistatin forms an essentially irreversible complex with activin (Schneyer et al., 1994) .
Activins have been shown to modulate morphogenetic events during early vertebrate development. Several laboratories have reported that activins are able to induce mesoderm in isolated Xenopus blastula animal cap explants (reviewed in Klein and Melton, 1994) , and ectopic expression of activin PA or fin subunit RNAs in Xenopus embryos results in the formation of a secondary body axis . Somewhat similar effects are observed in embryos injected with synthetic RNA encoding for ActR-II (Kondo et al., 1991) or ActR-IIB (Mathews et al., 1992) . Moreover, the mRNAs for activin BA or Pa subunits Dohrmann et al., 1993) , follistatin (Tashiro et al., 1991) , ActR-II (Kondo et al., 1991) and ActR-IIB (Mathews et al., 1992) are expressed during early stages of Xenopus development. Experiments based on a mutant ActR-IIB that inhibits activin signalling revealed that activin is required for the induction of mesoderm in vivo and the patterning of the Xenopus embryo body plan (Hemmati-Brivanlou and Melton, 1992) . More recent studies have suggested that activin could act as an inhibitor of neuralization whereas follistatin would have an opposite, permissive effect on neural tissue development in Xenopus embryos (Hemmati-Brivanlou et al., 1994) . Also in the early chicken embryo, exogenous activin induces axial structures and the activin /3n subunit is expressed at the time and place where mesodermal axial structures are induced (Mitrani et al., 1990) . During later chick development, activin is likely to regulate the differentiation of neural and skeletal tissues (KokanMoore et al., 1991; Ohuchi et al., 1992; Jiang et al., 1993; Chen et al., 1993) .
follistatin (Albano et al., 1994) were localized by in situ hybridization to the maternal decidua, but neither pA nor Pa subunit mRNAs were detected in the embryo at that time (Manova et al., 1992; Albano et al., 1994) . However, with the sensitive reverse-transcriptasepolymerase chain reaction (RT-PCR) method and immunohistochemistry, PA and /3n subunit transcripts and proteins were demonstrated in unfertilized mouse oocytes and early preimplantation embryos (van den Eijnden-van Raaij et al., 1992; Albano et al., 1993) as well as in postimplantation embryos (van den Eijndenvan Raaij et al., 1992; Albano et al., 1994) . Interestingly, exogenous activin induces the homolog of the homeobox gene goosecoid in the 6.4-day mouse epiblast, suggesting that it is involved in the regulation of early mammalian gastrulation (Blum et al., 1992) . As detected by RNAase protection assays of whole mouse embryo RNA, the expression of all three inhibin/activin subunits is not clearly detected prior to 10.5 days of development whereas follistatin transcripts appear as early as day 8.5 (Albano et al., 1994) . In 12-20 day rat embryos, PA mRNA is expressed in heart, skin, brain and several skeletal tissues, whereas fin expression is abundant in brain, salivary gland and gonads (Roberts et al., 1991) . In a more recent study, Roberts and Barth (1994) showed that follistatin transcripts show a wide tissue distribution pattern in the rat embryo beginning to be expressed at day 9 in neural tissues. From day 13-14 onwards, it is expressed in all tissues where either the 0~ and Pn subunit mRNAs or both are found. In the same study, the ActR-II expression was found to be confined to the developing neural tissues whereas the tissue distribution pattern of ActR-IIB transcripts was wider, close to that observed for follistatin. In mid-gestational human embryos, we detected by Northern blot hybridization the expression of the PA and /3a subunit and follistatin mRNAs in multiple tissues, notably in the developing neural, muscular and glandular tissues (Tuuri et al., 1994a) . Both the ActR-II and ActR-IIB are highly expressed in developing human neural and muscular tissues (Hildin et al., 1994) . In rat (Roberts and Barth, 1994) and human (Hilden et al., 1994) fetuses, A&R-IIB transcripts show a wider tissue distribution pattern than ActR-II. These recent reports on the expression of the transcripts for activin subunits, activin receptors and follistatin strongly suggest that the activin-follistatin system may play an important regulatory role in multiple tissues during mammalian organogenesis. However, no information on the direct effect of activin or follistatin on mammalian tissues undergoing organogenesis has been published. Recent reports have suggested that activin may also
Here we describe experiments designed to assess the play regulatory roles during mammalian development.
effect of exogenously added activin on the morphogeneIn 5.0-8.5-day post-implantation mouse embryos, the sis of developing mouse organ rudiments in culture. We mRNAs for the activin PA and the Pa subunits show that activin disrupts the lobulation of the develop- (Manova et al., 1992; Albano et al., 1994) as well as ing pancreatic and salivary gland epithelia and the nor-ma1 branching pattern of the ureter bud epithelium of the developing kidney. The effects of activin are particularly dramatic in the pancreas where the acinar epithelium almost completely fails to develop in the presence of activin. As these tissues appear to express activin subunit, follistatin or activin receptor mRNAs, we propose a potential role for the activin-follistatin system as an intrinsic regulator of epithelial branching morphogenesis.
Results

Activin disrupts normal epithelial lobulation in the developing pancreas
To determine the effect of activin on epithelial morphogenesis in developing mouse organs, we studied the effect of exogenous activin on pancreas, salivary gland and kidney rudiments in culture. The epithelial lobulation or branching morphogenesis of each of these tissues can be easily followed over a four-day culture period by whole-mount staining of the epithelia by specific antikeratin antibodies. In all of these organs, exogenously added recombinant human activin A had characteristic inhibitory effects on epithelial lobulation or branching morphogenesis.
The lobulation morphogenesis of the developing mouse pancreas is more sensitive to exogenous activin than the respective events in the salivary gland or kidney. When 1 l-day embryonic pancreatic anlagen are exposed to 0.75 nM (= 20 @ml) of activin, morphogenesis is severely impaired (Fig. 1B) and activin concentrations of 2.5 nM ( = 65 @ml) and above completely inhibit the formation of epithelial lobules. In these cultures, the pancreatic epithelium pinches off small vesicles and the remaining epithelial bud fails to invaginate the mesenchyme.
To exclude the possibility that the effect of activin on epithelial morphogenesis would be toxic, histological stainings were performed and no evidence of increased cell death of activin-treated cultures was revealed. We also tested the effect of the activin-binding protein follistatin on the in vitro development of epithelial branching morphogenesis affected by activin. In pancreatic rudiments treated with 6.0 nM recombinant human follistatin, epithelial lobulation proceeded normally (Fig. 1A) . The characteristic inhibitory effect of 0.75 nM activin on pancreatic epithelial lobulation (Fig. 1B) was completely prevented by co-incubation with 6.0 nM follistatin (Fig. 1C) . This control indicates that the effect of activin is specific and that the strong effect of activin on pancreatic epithelial lobulation is not toxic.
Activin disrupts normal epithelial lobulation in the developing salivary gland
When embryonic anlagen of mouse salivary glands are grown in medium containing activin, the branching of epithelial lobules is profoundly altered. The morphology of the salivary gland adenomeres changes dramatically when the 13-day embryonic rudiment is cultured in 7.5 nM (= 200 @ml) activin concentration for four days. Before two days, there are only slight differences between the control ( Fig. 2A) and activin-treated cul- Fig. 1 . The effect of activin on pancreatic epithelial morphogenesis.
Pancreas rudiments of 1 l-day embryos were cultured for four days in medium containing 6.0 nM follistatin (A), 0.75 nM activin (B) or both factors (C). Control cultures were similar to A and C. In the experiments where activin and follistatin were given simultaneously, the factors had heen incubated together for 30 min at 37°C prior to adding them to the organ cultures. All organ anlagen were stained as wholemounts for cytokeratin 18. 2. Effect of activin on salivary gland epithelial morphogenesis. Salivary gland rudiments of 13.5day embryos were cultured for two da) B) or four days (C and D) in medium without activin (A and C) or in medium supplemented with 7.5 nM activin (B and C). The foul ures were replenished with fresh media after two days of culture. All organ anlagen were stained as whole-mounts for cytokeratin 8.
IS (A *-day tures (Fig. 2B) . However, from day 3 onwards, the adenomeres of the activin-treated anlagen begin to coalesce, creating globular bulges out of the individual lobules (Fig. 2D ). The effect of activin was concentration-dependent since at 2.5 nM the effect was less profound than at 7.5 nM, whereas at 0.75 nM it did not produce any alterations in salivary gland epithelial morphogenesis. Follistatin partially inhibited the effects of activin in the salivary gland cultures (not shown).
Activin disrupts normal epithelial branching in the developing kidney
We also analyzed the effect of increasing concentrations of activin on the epithelial differentiation and branching morphogenesis of embryonic mouse kidneys in organotypic cultures (Saxen, 1987) . Kidney anlagen cultured in control media showed the pattern of epithelial branching characteristic of the developing mouse kidney (Fig. 3A-C) . Rudiments from the same litter developed in a very different pattern when cultured in medium containing 7.5 nM activin (Fig. 3D-F) . Branching in these activin-treated anlagen was delayed and characterized by abnormally short intercalating distances between branches and by failure to produce as many secondary branches as did the control kidneys. The ureter branches in activin-treated cultures were able to induce the surrounding mesenchyme to form the secretory part of the nephron characterized by the expression of the brush border antigen ( Fig. 3C and F) , thus showing the viability of both the inducing and responding tissues.
The effect on kidney rudiments was seen only at relatively high activin concentrations. At 2.5 nM, activin did not affect the branching of the ureter bud epitheliurn. When 1 l-day mouse kidney anlagen were cultured in medium containing 7.5 nM activin, and the medium was not renewed during the four-day culture period, the primary branches formed abnormally, but the secondary branches appeared to form more like those of the controls ( Fig. 4B and C) than those given fresh activincontaining medium after two days in culture (Fig. 3F) . A similar reversibility of the activin-induced effect was obtained when the kidney anlagen were transferred into normal medium after a two-day activin treatment (not shown). When the kidneys were first cultured for two days in the absence and for two more days in the presence of exogenous activin, the primary branches formed normally but the secondary branches still Fig. 3 . Effect of activin on kidney epithehal branching morphogenesis. Kidney rudiments of I l-day embryos were cultured in the absence (A-C) or the presence of 7.5 nM activin (D-F) for one day (A and D), two days (B and E) or four days (C and F). The four-day cultures were replenished with control (C) or activin-containing (F) media after the first two days of culture. The ureter epithelium is visualized with an antibody against cytokeratin 8 (yellow-green color; A-F). In (C) and (F), double-labeling with antibodies against cytokeratin 8 and brush border antigen of the secretory nephron (red color) shows the viability of both the inducing and responding tissues. 1 l-day embryos were cultured in the absence (A) or presence of 7.5 nM activin (B and C) for four days without replenishment of media. In (B) and (C), note the inhibition of primary branch formation, whereas the secondary branches develop more like those of the controls (Figs. 3C, 4A and D) than those of kidneys given fresh activin after two days in culture (Fig. 3F ). Cultures (D-F) were tirst grown for two days in control medium and for the following two days, in control medium (D) or 7.5 nM activin (E and F). In (E) and (B), the primary branches appear to form normally, whereas the development of secondary branches is impaired. All kidney anlagen were stained as whole-mounts for cytokeratin 8.
became abnormal in shape (Fig. 4E and F) . These results show that the effect of activin on the epithelial branching of the mouse kidney anlagen is concentration-dependent, reversible and observable at several stages of kidney organogenesis. Exogenously added follistatin partially inhibited the effect of activin on ureter epithelium branching (not shown).
TGF-8 disrupts normal epithelial branching in the developing kidney in a manner distinct from that of activin
To study whether the effects observed are specific for activin, we tested how the structurally related TGF-/3 family members inhibin A, TGF-/3 and TGF-/32 affect kidney development in vitro. Inhibin A which antagonizes the effect of activin in some, but not all, systems (reviewed in Vale et al., 1990 ) had no effect by itself and did not inhibit that of activin at any concentration used (not shown). Previous immunohistochemical studies have suggested a role for TGF-fil-3 during mouse kidney development; TGF-P2 appears in this tissue at 12.5 days of gestation (Pelton et al., 1991) . In our culture system, TGF-8 1 caused, in a concentration-dependent manner (0.3-3.0 nM), branching abnormalities of the ureter bud that were clearly distinct from those seen for activin. In 1 l-day kidneys treated with TGF-81 (1.0 nM) for four days, the ureter bud appeared to grow rapidly in length and did not branch until it reached the periphery of the metanephric mesenchyme (Fig. 5C ). These branches formed in an 'arcade' fashion, producing an umbrella of tubules. Longer distances between ureter branching points were observed in TGF-/31-treated kidneys when compared with control kidneys (Fig. 5A) . Interestingly, kidneys treated with both activin and TGF-@I showed a combination of the characteristic effects of both factors, and TGF-02 had an effect similar to that of TGF-j3 1 (not shown). Like activin, TGF-81 did not disturb the induction of the secretory nephrons as demonstrated by staining for brush border antigen (Fig. 5D ).
Activin, follistatin and activin receptor mRNAs are expressed in tissues undergoing branching morphogenesis
A prerequisite for an intrinsic regulatory role of the activin-follistatin system during the development of mouse organs undergoing epithelial branching morphogenesis is the presence of activins, follistatin and activin (A Lrn an , and after receptors in these tissues. As inhibimactivin subunit (Meunier et al., 1988) and follistatin (Shimasaki et al., 1989; Michel et al., 1990) mRNAs are relatively weakly expressed in several adult extragonadal tissues, we used the sensitive RT-PCR method and Southern blotting for their detection in embryonic tissues. When sensitivity allowed, transcripts were visualized by Northern analysis using single-stranded DNA or RNA probes. Oligonucleotide primers designed according to human inhibimactivin subunit (Mason et al., 1986) and follistatin (Shimasaki et al., 1988) sequences with high homology to the respective rat genes (Shimasaki et al., 1989; Esch et al., 1987) yielded PCR fragments of expected length when mouse RNA was employed as template in RT-PCR. To avoid genomic DNA contamination of the samples, the primer sequences were chosen so that the 
Activin f3~
Follistatin Act-RIIB pactin Fig. 7 . Northern blot analyses of activin fla, follistatin, ActR-IIB and fl-actin mRNAs in developing mouse tissues. About 10 cg of total denatured RNA from IS-17day embryonic mouse kidneys (lane I), salivary gland (lane 2), lung (lane 3) and brain (lane 4) were run in 1.5% agarose gels and Northern transfers hybridized with specific single-stranded cDNA or cRNA probes. For Be, a IO-day exposure is shown of a filter probed with a 756bp single-stranded cDNA prepared from a mouse ovary RT-PCR clone, For follistatin, the autoradiogram represents a 24-day exposure of a filter probed with a cRNA probe prepared from the 66%bp mouse ovary RT-PCR clone. Human single-stranded cDNA probes from 959-bp ActR-IIB, (18-day exposure) and 263-bp @-actin (18-h exposure) PCR-derived clones were used to visualize the respective mouse transcripts. The migration of ribosomal 18s and 28s RNA is indicated.
PCR products arising from tissue RNA-derived cDNAs would be shorter than the respective genomic DNA fragments, assuming that the exon-intron structures of human and rat genes are conserved in the respective mouse genes (Shimasaki et al., 1988 and Stewart et al., 1986; Mason et al., 1989) .
The embryonic mouse salivary gland, pancreas and kidney expressed mRNAs for follistatin (Fig. 6A ) and the activin flA subunit (Fig. 6B) . RT-PCR analysis also detected the j3s subunit in the salivary gland (not shown). As expected, adult mouse ovaries and kidneys and adult rat ovaries expressed both follistatin (Fig. 6A ) and the activin BA subunit (Fig. 6B) , and the ovaries of both rodents expressed the o and Ba subunits (not shown). Although lacking the sensitivity of RT-PCR, Northern hybridization confirmed the presence of the about 3.8 and 4.8-kb activin Pa subunit transcripts in embryonic salivary gland and brain which served as a positive control (Fig. 7) . The low copy number of flA subunit mRNAs prevented their detection with this assay. The 2.5kb follistatin transcript was clearly demonstrable in the developing salivary gland (Fig. 7 ). An about 2.2 kb ActR-IIB transcript, corresponding in size to rat and mouse ActR-IIB mRNAs reported by others (Feng et al., 1992) , was detected in the mouse embryonic kidney, salivary gland, lung and brain (Fig. 7) . The ActR-II 6.0 and 3.0-kb messages give a very weak hybridization signal in the developing kidney (not shown). We find that transcripts of similar sizes for activin j3s, follistatin and ActR-IIB are also detectable in adult mouse kidneys, salivary glands and pancreas (Tuuri et al., manuscript in preparation To determine the localization of activin subunit, follistatin and activin receptor transcripts in the developing salivary gland, kidney and pancreas in situ hybridization was performed on serial sections of tissues taken on days 15, 17 and 19. In probe control experiments, we found that our mouse flA and Pa subunit and follistatin antisense [3'Sl-cRNAs detect strong specific hybridization signals in granulosa cells of adult mouse ovarian follicles (not shown), as expected. However, under our stringent hybridization conditions, our human ActR-II and ActR-IIB antisense [ 3SS]-cRNAs failed to detect the respective mouse transcripts.
In RT-PCR and Northern hybridization analyses of salivary gland RNA, the expression of the /3A subunit transcripts was clearly weaker than that of the Pa subunit and follistatin. This result is supported by the in situ hybridization experiments which show that the oA transcripts are found in the developing salivary gland only in smooth muscle cells surrounding the salivary duct and some larger vessels ( Fig. 8A and B ). By contrast, the Pa subunit transcripts are abundantly expressed in the developing salivary epithelium at day 15, 17 and 19 ( Fig. 8C and D) . The expression of the &I transcripts increase progressively with increasing gestational age being highest at day 19. Follistatin transcripts are highly expressed in mesenchymal cells surrounding the branching acinar epithelium at days 15, 17 and 19 ( Fig. 8E and F) . A weaker follistatin hybridization signal is detected in salivary gland epithelial cells increasing progressively with increasing gestational age. Fig. 8G indicates that a low background signal is obtained with the follistatin sense control probe in the salivary gland.
In the developing kidney, in situ hybridization revealed that follistatin transcripts are clearly expressed in the kidney capsule (Fig. 81 and J) and in the connective tissue surrounding the ureter, but no detectable signal was observed in the branching ureter epithelium or developing nephrons. The Pa subunit transcripts were also detected in the capsular tissue, but their expression was clearly weaker than that of the follistatin mRNAs (not shown). A weak hybridization signal is detected for the /IA subunit transcripts in smooth muscle cells surrounding the ureter. Neither /3 subunits were thus detected in ureter epithelium or developing nephrons at the developmental stages studied.
As expected from the RT-PCR analyses, the expression of activin /3* and &, subunit and follistatin transcripts was weak in the developing pancreas. The activin flA subunit mRNAs were not clearly detected in any pancreatic cell types (not shown). By contrast, both follistatin ( Fig. 8K and L) and the activin &, subunit (Fig. 8M and N) transcripts were unequivocally localized to individual cells or cell clusters around the pancreatic acinar epithelium. The exact identity of these interstitial cells is at present unclear to us. We cannot exclude the possibility that they could be Langerhans islet cells that have been shown to express inhibimactivin subunit and follistatin mRNAs in the adult rat (Ogawa et al., 1993; Yasuda et al., 1993) . A weak hybridization signal for the Pa subunit but no clear signal for follistatin were detected in the pancreatic epithelium. A common feature to our in situ hybridization experiments with pancreas sections was a whitish glow observed on the pancreatic acinar epithelium which was present with both antisense and sense probes in dark field microscopy (Fig. 8K, M and 0) . This, however, did not adversely affect the interpretation of the results.
Mouse activin PA and Be subunit and follistatin cDNAs are highly homologous to their counterparts in other mammals
The mouse RT-PCR products encoding parts of the reading frames of the mouse activin PA and &, .subunits and follistatin were subcloned in plasmid vectors and their cDNA sequences determined from several independent clones. Morever, the full-length mouse follistatin (Mason et al., 1986; Shimasaki et al., 1988) . Amino acid substitutions as compared with the human sequences are indicated. For the activin &, subunit, the portion of the protein representing the mature hormone is underlined. For follistatin, the 344-aa form of the protein sequence is shown. In cDNAs encoding the 343-aa form, the Lys and Ala residues at positions 241 and 242, respectively (underlined), are replaced by a single Thr corresponding to the results of Albano et al. (1994) . Only segments of cDNA sequence located between the amplification primers have been translated to amino acids and shown in the figure. cDNAs were obtained from mouse ovary by RT-PCR using primers used to amplify the whole reading frame of the human 344 amino acid (aa) follistatin isoform (Tuuri et al., 1994b) .
From the cDNA sequence flanked by primers used for amplifying the 781-bp mouse activin flA fragment, we deduced a protein sequence of 243 aa with 94.4% and 99.6% homology to the respective areas of human (Mason et al,. 1986 ) and rat (Esch et al., 1987) sequences. Our partial clone is identical in sequence and confirms the full-length mouse PA cDNA sequence recently published by Albano et al. (1993) during the preparation of this report.
A 234-aa sequence encoding the mouse activin &, subunit was deduced from the respective 756-bp RT-PCR product (Fig. 9A) . Assuming that the full-length mouse fiB subunit is similar in length to the human 407-aa preproactivin & protein (Mason et al., 1989) , our partial sequence encodes about 58% of the mouse protein. The partial mouse flu protein sequence is 96.6% and 100% homologous to the respective regions of the human and rat sequences (Mason et al., 1989; Esch et al., 1987) . Our fragment encompasses 140 aa of the Nterminal proregion and 94 amino acids of the C-terminal 115-aa mature region. Albano et al. (1993) recently published a partial mouse ovary 0s cDNA sequence Several partial 668-bp and full-length 1053-bp mouse follistatin cDNAs were characterized by sequencing. The longer cDNAs correspond to the 344 aa form of follistatin of which the 336 aa flanked by our primers are depicted in Fig. 9B . In the mouse sequence, we find 6 aa substitutions as compared to the human sequence and the protein has 98.4% and 99.4% amino acid homology to the human and rat sequences, respectively (Shimasaki et al., 1988 and . A partial mouse follistatin cDNA clone derived by RT-PCR from an osteoblast cell line was recently published (Hashimoto et al., 1992) . Our sequence is otherwise in agreement with it except that we find a Lys corresponding to the human Arg at position 163 (counting from the initiation Met), whereas Hashimoto et al. (1992) report a Leu at that site. During the revision phase of the present report, Albano et al. (1994) published the sequence of the full open reading frame of the mouse follistatin cDNA which was derived from overlapping RT-PCR fragments and a cDNA isolated from a mouse ovary X library. They report the same 6 aa substitutions we found in the deduced protein sequence as compared to the respective human sequence and, in agreement with our results, they report a Lys residue at 163. However, they claim that the 344-aa form found in other mammals would be 343 aa in the mouse. Their cDNA encodes for a Thr at position 241 followed by a Lys at position 242, whereas we find that the sequence Lys24,-Ala242-Lys243 found in other species is intact in the mouse sequence. We cloned additional RT-PCR fragments to clarify this discrepancy and found that part of the cDNAs encode the 344-aa form whereas some encode the 343-aa follistatin also found by Albano et al. (1994) . Although the genomic sequence of mouse follistatin has not been characterized, we suspect that these cDNA isoforms represent alternatively spliced follistatin transcripts. Alternative splicing of the follistatin transcript has not previously been reported at this site in other species, but both the human (Shimasaki et al., 1988) and rat (Shimasaki et al., 1989) genomic follistatin sequences contain donor and acceptor sites enabling the splicing of the transcript variants found in the mouse.
Discussion
The results presented here show that activin modulates epithelial branching morphogenesis in developing mouse pancreas, salivary gland and kidney rudiments in culture. Exogenous activin has a characteristic inhibitory effect on the formation of epithelial lobules or branches in these organs. The effect is specific for activin as it was neutralized by follistatin and clearly different from that observed for TGF-PI, another member of the TGF-/3 family of growth and differentiation factors.
The most profound effect of activin on epithelial morphogenesis was observed in the developing pancreas. The lobulation of pancreatic epithelium was severely affected at lower concentrations of activin than were the respective processes in the salivary gland or kidney. Moreover, exogenous follistatin completely neutralized the effect of activin, further demonstrating the specificity of the activin effect. It is possible that the pancreas is more vulnerable to the effects of activin than the salivary gland and kidney because it does not show a similar intense capsular or peripheral expression of endogenous follistatin as detected by in situ hybridization for these two other glandular organs. Our RT-PCR studies indicated that low levels of activin and follistatin are expressed in the developing pancreas. Particularly, in situ hybridization studies indicated that isolated interstitial cells surrounding the pancreatic acinar epitheliurn express the /3a subunit and follistatin mRNAs, but the exact identity of these cells remained unclear. Recent evidence shows that cell lineages resulting in the formation of the endocrine pancreas diverge at a premorphogenetic phase, i.e. before the formation of the pancreatic diverticulum at about day 10 of gestation, whereas the exocrine cells differentiate slightly later (Gittes and Rutter, 1992) . In the present study, activin completely blocked the development of the exocrine pancreas. The fate of the Langerhans islet cells after activin treatment was not specifically studied but it will be a matter to resolve in future studies. Interestingly, activin subunits and follistatin were recently shown to be expressed in adult rat Langerhans islets (Ogawa et al., 1993; Yasuda et al., 1993 ) and activin appears to stimulate insulin secretion from the endocrine pancreas (Totsuka et al., 1988) . Thus, activin may regulate the development and function of both the exocrine and endocrine pancreas.
In the salivary gland, activin had profound effects on epithelial lobulation morphogenesis. Interlobular clefts disappeared completely due to the fusion of adenomeres in rudiments cultured for four days with activin. Roberts et al. (1991) reported that activin Pa subunit mRNAs are expressed in the developing rat salivary gland, and the present study shows the expression of& and PA together with follistatin and ActR-IIB mRNAs in the developing mouse salivary gland. In a recent study, Roberts and Barth (1994) have confirmed the expression of follistatin and ActRIIB in the developing rat salivary gland but, from their study, the exact cellular localization of the transcripts was not clear due to the thickness of the sections used. In our in situ hybridization experiments, follistatin was found to be mainly expressed in the mesenchymal cells surrounding the salivary epithelium whereas the Pa subunit transcripts were confined to the epithelium. To understand the role of the endogenous activin-follistatin system in salivary organogenesis, it will be important to resolve in future studies what cells are responsive to the effects of activin and how the secreted protein have access to the receptors of the responding cells. The biological processes that mediate the characteristic effect of activin on epithelial morphogenesis in the salivary gland are currently not known. Local degradation and remodeling of the basement membrane has been postulated to be a mechanism controlling epithelial branching at particular sites (Bernfield et al., 1984) . Interestingly, exogenous collagenase (Grobstein and Cohen, 1965; Nakanishi et al., 1986) and hyaluronidase (Banerjee et al., 1977) reorganize the extracellular matrix of salivary gland rudiments and cause adenomeres to coalesce in a manner quite similar to that observed with activin. We hypothesize that endogenous activin is one of the regulators participating to the local remodeling of extracellular matrices and it could thus affect branching. Activin was recently shown to inhibit type II collagen mRNA expression and induce NCAM and tenascin deposition (Jiang et al., 1993) during chick limb bud chondrogenesis, but effects of activin on extracellular matrix formation in other modelsystems have not been described.
Concentration-dependence studies indicated that the activin effect on kidney epithelial branching morphogenesis was clearly observed only with relatively high activin concentrations (7.5 nM). We also noticed that during our four-day culture period, the ureter epitheliurn began to recover from the inhibitory effect of activin unless fresh activin-containing medium was changed after 2 days. Both of these observations indicate that exogenous activin is either degraded or neutralized in the explant during culture. Ongoing synthesis of the activinbinding protein follistatin or other activin-binding proteins would explain this phenomenon by the neutralizing effect. The present demonstration of the follistatin mRNA in the developing kidney favors this hypothesis. We observed relatively low follistatin mRNA levels in whole tissue RNA from the developing kidney as compared with, for example, the salivary gland. However, the in situ hybridization data on the specific localization of follistatin transcripts in the kidney capsule may explain why the kidney explants were only responsive to high doses of activin. If the follistatin protein is effectively produced by capsule cells, the exogenously added activin would be largely inactivated before reaching its possible targets. In regard to the recently described unusual property of follistatin to irreversibely bind activin at physiological pH (Schneyer et al., 1994) , the inactivation process would be more complete than in the case where the growth factor binding protein complex formation would obey the more commonly observed equilibrium kinetics. On the other hand, follistatin may not be the sole relevant activin binding protein modulating the actions of activin. In addition to follistatin, only one other protein, ar2 macroglobulin, has been reported so far to bind activin, but this protein does not neutralize its biological effects like follistatin . However, it is likely that other extracellular proteins may bind activin and modulate its biological activity as several such proteins have been described for other TGF-8 family members. For example, some of the TGFfl and bone morphogenetic protein isotypes have been reported to bind to several non-receptor membrane proteins (reviewed in Massague, 1992) and extracellular matrix components such as collagens and proteoglycans (reviewed in Ruoslahti and Yamaguchi, 1991; Paralkar et al., 1991 and 1992) .
A few reports have demonstrated the presence of activin, follistatin or activin receptors in the kidneys of different mammalian species, but no specific biological effect of the activin-follistatin system has previously been described in this tissue. A protein isolated from calf kidney, termed vegetalizing factor, is likely to represent the bovine activin on the basis of its mesoderm-inducing and erythroid differentiation factor-like activities (Tiedemann et al., 1992) . The expression of follistatin was recently reported in the embryonic rat kidney (Roberts and Barth, 1994) and, during postnatal development of rat kidney, follistatin mRNA levels are detected throughout the infantile period, increasing steadily towards adulthood (Michel et al., 1991) . Follistatin mRNA and protein have been localized to the collecting tubules of the outer medulla of the adult rat kidney (Shimasaki et al., 1989; Kogawa et al., 1991) . ActR-II mRNA expression was also recently reported in the adult mouse kidney (Mathews and Vale, 1991) and, together with ActR-IIB, in the developing human kidney (Hilden et al., 1994) . Furthermore, Act-RI, which acts together with Act-RIIs in tranducing the cellular effects of activin, is expressed in the 15day embryonic rat urogenital ridge (He et al., 1993) as well as in the adult rat (Matsuzaki et al., 1993) and human (ten Dijke et al., 1993; Attisano et al., 1993) kidneys. We now report that a&in PA, follistatin and ActR-IIB mRNAs are expressed in 15-17-day mouse embryonic kidneys. ActR-IIB was detected by Northern analysis, whereas the former two transcripts could only be demonstrated by the more sensitive RT-PCR analysis. The paucity of activin and follistatin transcripts in the developing kidney may reflect low overall expression of these genes or, more probably, a restricted distribution of the transcripts within this tissue. This was confirmed with our demonstration of the local expression of follistatin transcripts in the kidney capsule and that of the flA subunit in smooth muscle tissue surrounding the ureter. Our study shows that excessive activin tissue concentrations are clearly deleterious for epithelial branching morphogenesis. As for the pancreas and salivary glands, further efforts in characterizing the cells responsive for the activin effect have to be made to clarify the biological role of the endogenous activin-follistatin system during kidney development.
Two recent report from independent laboratories described the phenotypes of mice strains that carried null mutations at the /3n gene (Vassalli et al., 1994; Schrewe et al., 1994) . The homozygous mutant animals are born with surprisingly few defects. Less than half of these &-mutant mice are born with eyes open, suggesting that activin Pa subunit may be involved in the regulation of eye development. The flu knock-out mice are fertile but females exhibit a characteristic reproductive defect associated with the inability to foster their offspring because milk production fails to begin normally. It has been suggested that activin @s subunit would be involved in the regulation of decidual oxytocin production which is necessary for the initiation of lactation. Although the @a subunit is highly expressed in several embryonic tissue such as the salivary gland, brain and gonads, no defects in the development of these organs has been detected in the mutant mice. It is possible that the /IA subunit may correct the Pa subunit deticiency and therefore the apparent defects in these phenotypes would be so few. During development, maternal supply of activins could also mask some of the defects as shown recently in TGF-/31 deficient mice (Letterio et al., 1994) . Future studies on follistatin and activin receptor deficient mice and possibly on activin PA and @a subunit double knock-out mice may shed light on our understanding of the role of the endogenous activin-follistatin system as a regulator of epithelial branching morphogenesis.
This study describes a novel biological activity for the activin-follistatin system as a regulator of epithelial branching morphogenesis in several glandular organs. TGF-01 also appears to modulate epithelial branching morphogenesis but in a manner distinct from that of activin. The inhibitory role of TGF-P on branching morphogenesis has been recently described also in the mammary gland (Silbertstein et al., 1992) and lung (Serra et al., 1994) . Several studies have shown that TGF-fll promotes the synthesis of collagen and other extracellular matrix components (reviewed in Massague, 1990) that are known to be critical in branch formation and stabilization (Nakanishi et al., 1986 , Silberstein et al., 1992 . It is possible that TGF-/31 is acting to stabilize the extracellular matrix of the epithelial branches. Interestingly, TGF-81 was also recently shown to inhibit both tubule formation and branching induced by hepatocyte growth factor (HGF)/scatter factor in the MadinDarby canine kidney cell system (Santos and Nigam, 1993) . More recently, HGF has been shown to be directly involved in the induction of epithelial branching morphogenesis of embryonic mouse kidney rudiment cultures in vitro (Santos et al., 1994) . Thus, it is likely that a tightly controlled equilibrium of factors inducing and inhibiting branching morphogenesis is needed for the normal development of mammalian glandular organs. The results reported here support the general notion that the closely related TGF-8 family members are potent modulators of mammalian development and add yet a new aspect to the wide array of biological effects these factors have.
Experimental procedures
Organ culture
Organ anlagen were dissected from mouse embryos of different developmental stages obtained from timed matings of CBA males and NMRI females. The appearance of the vaginal plug was noted as day 0. The tissues were cultured on Nuclepore membrane filters (Costar) placed on stainless steel grids as described previously (Saxen and Lehtonen, 1978) . The rudiments were incubated in 100 ~1 or 900 ~1 of Eagle's Minimum Essential Medium supplemented with 10% heatinactivated fetal calf serum (Myoclone Plus; GIBCO), penicillin (100 IU/ml) and streptomycin (100 &ml), in 5% CO2 humidified atmosphere. Purified human recombinant activin A (Ajinomoto Inc.) was added to the organ rudiments in culture for different time periods at indicated concentrations. In our study, the protein migrates as a single 25 kDa band in SDS-PAGE and it induces hemoglobin synthesis in human K562 erythroleukemia cells at an EDso of about 0.2 nM (Eramaa et al., 1992a) , which is consistent with the results obtained by others . Bovine inhibin A was from Peninsula Labs Europe. Human recombinant TGF-81 and porcine platelet TGF-02 were purchased from British Biotechnology. Purified human recombinant follistatin was supplied by the National Institute of Child Health and Human Development, NIH. All organ culture experiments were performed at least three times with similar results.
Whole mount immunohistochemistry
For immunofluorescence histochemistry, mouse organs cultured in the presence or absence of exogenous factors were fixed in methanol after different incubation periods. The developing organs were stained as wholemounts (Sariola et al., 1988) using TROMA-1, a rat monoclonal antibody to mouse cytokeratin 8 (Kemler et al., 1981) or the mouse monoclonal antibody PKK3 to porcine cytokeratin 18 (Lehtonen et al., 1985) . The brush border of secretory nephrons of developing kidneys was recognized with rabbit polyclonal antibodies to rat kidney brush border antigen (Ekblom et al., 1980) . The primary antibodies were reacted with FITC-or TRITC-conjugated goat anti-rat (Dako) and anti-mouse IgGs (Jackson Immunores. Inc) or donkey anti-rabbit IgGs (Jackson), and immunofluorescence was visualized by a Zeiss Axiophot microscope with epifluorescence.
RNA preparation and reverse transcription
Total RNA from dissected mouse embryonic and adult organs was extracted with the guanidine isothiocyanate-cesium chloride method (Chirgwin et al., 1979) and quantitated by absorbance at 260 nm. Two micrograms of total tissue specific RNA was used for reverse transcription (RT) performed at 37°C for 1 h. The IO-p1 reaction contained 0.5 ~1 of cloned MMLV-RT (BRL; 200 U/pi), 0.2 rg of oligo-dT primer (Boehringer Mannheim), 2 ~1 of RT buffer (BRL), the four dNTPs at 0.5 mM and 5 U human placental RNAse inhibitor (Amersham). The reaction mixtures were aliquoted and stored at -70°C until used directly in PCR reactions.
Primers for PCR
Primers for amplification for mouse inhibimactivin (II, bA and pa subunits and follistatin were designed according to DNA sequence within the protein encoding regions of respective human cDNAs (Mason et al., 1986; Shimasaki et al., 1988) . The o-subunit primers, (5' to 3') CAGCCACAGATGCCAGCTGT and CTCCGG-AGGCCTCTGCAGCAGGCCCAG, PA-subunit primers, GTTTGCCGAGTCAGGAACAG and GAGGT-TGGGCAAAGGGGCTATGGCCCCGCAT, and Pasub-unit primers, TTCGCCGAGACAGATGGCCT and GGCACGTCCCGCTTGACGATGTTGTACTC, yield 502-bp (Erlimaa et al., 1992b ), 787-bp (Erimaa et al., 1992a and 756-bp fragments (Edmaa et al., 1993) respectively, in RT-PCR on human target RNA. Mouse follistatin was amplified with human foIlistatin primers, GACCGCAGTGCCCAGGCTGG and TTCACAG-GACTTTGCTTTGA, which yield a 668-bp fragment from human ovarian RNA (Tuuri et al., 1994b) . The 668-bp mouse follistatin cDNA clone was used to generate probes for filter and in situ hybridization experiments. Another set of primers used to generate a 1053-bp human follistatin cDNA covering the whole reading frame of the 344-aa follistatin isoform was used to amplify the respective mouse cDNAs (Tuuri et al., 1994b) . The human P-actin primers, CCCAGGCAC-CAGGGCGTGAT and TCAAACATGATCTGG-GTCAT, yielding a 263-bp fragment in RT-PCR of human RNA (Erlmaa et al., 1992a) were used as an internal control for RNA integrity in mouse RT-PCRs.
PCR on whole cDNA populations
For each PCR reaction, we mixed 0.5 ~1 of 5 U/p1 Taq DNA polymerase (AmpliTaq; Perkin Elmer), 5 ~1 of 10 x Taq buffer (Perkin Elmer), 0.5 ~1 of 10 mM dNTPs, 0.4 ~1 of each specific 5 ' end and 3 ' end, 50 PM primer stocks and 37 ~1 of HzO. Then 1 ~1 of tissuespecific RT mixes (corresponding to about 0.2 pg RNA) was added to the each tube, and the samples were overlaid with mineral oil. The reactions were performed in three steps: denaturation at 94°C for 30 s, annealing at 54°C for 30 s and elongation at 72°C for 1 min 30 s. Thirty-five cycles were performed for RT-PCRs of CX-, BA-, Pa-subunits, follistatin and fl-actin from mouse and rat tissues. In mouse tissue RT-PCRs, a RT mix without target RNA served as a negative control. 4.5.1. cDNA isolation, subcloning and sequencing. PCR products were excised from low-melting point agarose gels after electrophoresis and purified with the use of GeneClean (Bio 101) or Magic PCR prep (Promega) systems. The cDNAs were then directly ligated to a dTtailed (Marchuk et al., 1991) Eco-RV-linearized pGEM-5Z(+) plasmid (Promega) or the commercial T-vectors, pCRlOO0 (Invitrogen) or pGEM-T (Promega). Dideoxy chain termination sequencing of double-stranded plasmid template clones was performed using cloned T7 DNA polymerase (Sequenase; US Biochemicals). Mouse BA-subunit sequence was determined from three independent ovarian clones, &subunit from six ovarian clones, the 668-bp follistatin fragment from two ovarian and three adult kidney-derived clones, and the full-length 1053-bp and 1050-bp follistatin fragments from ovarian clones. The PCR-derived partial human cDNAs for fi-actin, the inhibimactivin Q-, PA-, and pasubunits, follistatin (Tuuri et al., 1994b) , ActR-II and ActR-IIB, (Hilden et al., 1994) were also subcloned into plasmid vectors, sequenced and used as hybridization probes.
Southern and Northern blotting
Fifteen microliters of RT-PCR products amplified from mouse tissues were electrophorezed through 2% agarose gels, denatured, neutralized and transferred onto Hybond N Nylon membranes according to standard methods. Mouse tissue total RNA samples (10 pg) were denatured for 60 min at 50°C in 1 M glyoxal-50% DMSO and run in 1.5% agarose gels and transferred by capillary diffusion on to Hybond N. DNA and RNA were cross-linked to the membranes by UV irradiation and baking for l-2 h at 80°C.
cDNA and cRNA probe labeling and hybridizations
Double stranded human /3-actin, the inhibimactivin (Y-, /3~-and &subunits and follistatin insert cDNAs were labeled with [32P]-o-dCTP (3000 Ci/mmol; Amersham) and a random-priming labeling kit (Boehringer Mannheim) and used for detecting respective mouse RT-PCR products in Southern transfers. For Northern analysis, [ 32P]-ar-dCTP-labeled single-stranded cDNA probes generated by linear amplification (Eramaa et al., 1993) or in vitro transcribed [32P]-ar-UTP-labeled (Amersham) cRNA probes (Melton et al., 1984) were used due to the low expression levels of target mRNAs. For single-stranded cDNA probes, 30 linear amplification cycles (94"C-30 s; 52"C-30 s; 72"C-1 min) were performed. The ~-PI labeling mixes contained linearized plasmid DNA in an amount equivalent to 5 ng of cDNA insert of interest, 1 PM specific 3 'end antisense primer, 50 PM dATP, dGTP and dTTP, and 1.6 PM [32P]-crdCTP (40 &i). The probes were purified with NucTrap columns (Stratagene) and used at l-3 x lo6 dpm/ml in hybridization solution containing 50% formamide, 6 x SSC (1 x SSC: 0.15 M NaCl, 0.15 M sodium citrate [pH 7:0]), 5 x Denhardt's solution, 100 &ml salmon sperm DNA and 100 pg/ml yeast RNA and 0.5% SDS. With cDNA probes, Southern and Northern blots were hybridized for 16 h at 42°C and washed three times 20 min with 1 x SSC, 0.1% SDS at 55°C. Hybridizations with cRNA probes were performed at 65°C for 12 h and washed three times 20 min with 0.1 x SSC, 0.1% S.D.S at 70°C.
In situ hybridizations
For in situ hybridization analyses, the [35S]-c&JTP labeled antisense and sense cRNA probes were in vitro transcribed from linearized pGEM-7Zf-or pGEM-SZf+ plasmids containing the 781-bp PA-subunit, 756-bp &,-subunit or 668-bp follistatin insert cDNAs cloned from mouse ovaries by RT-PCR as described above. Salivary gland, pancreas and kidney specimens from day 15, 17 and 19 mouse embryos as well as ovaries of pregnant mice were fixed and serial sections of each tissues were prepared; hybridizations and washes of the slides were performed exactly as described by Wilkinson and Green (1990) . Autoradiographic signals were photographed on Kodak TMAX film using an Zeiss Axiophot dark field microscope.
